Potentiation of insulin-like growth factor action by insulin-like growth factor binding protein-3: studies of underlying mechanism.
Conover
C A
CA
Endocrine Research Unit, Mayo Clinic, Rochester, MN 55905.
Bale
L K
LK
Clarkson
J T
JT
Durham
S K
SK
D000818:Animals; D002352:Carrier Proteins / Q000494:pharmacology*; D002417:Cattle; D002478:Cells, Cultured; D004357:Drug Synergism; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism; D018969:Insulin-Like Growth Factor Binding Proteins; D017526:Receptor, IGF Type 1 / Q000378:metabolism; D013002:Somatomedins / Q000378:metabolism / Q000494:pharmacology*; D013936:Thymidine / Q000378:metabolism
D002352:Carrier Proteins; D018969:Insulin-Like Growth Factor Binding Proteins; D013002:Somatomedins; D017526:Receptor, IGF Type 1; D013936:Thymidine